Herbalife Nutrition Renews Contract with Brand Ambassador Yo Yossavadee to Continue Promoting Healthy, Active Lifestyle

Food and Healthcare Press Releases Tuesday February 5, 2019 09:51
Bangkok--5 Feb--Francom Asia

Thailand - Herbalife Nutrition, a premier global nutrition company whose purpose is to make the world healthier and happier, recently renewed its contract with famous sports athlete Yossavadee Hassadeevichit (Yo), as Herbalife Nutrition Thailand Brand Ambassador.

Yo's assignment in this prestigious role is to project Herbalife Nutrition's philosophy that focuses on a healthy, active lifestyle that integrates proper nutrition and regular exercise, through all media channels and the various sports events lined up for the year nationwide.

"When Yo decided to become a full-time athlete several years ago, she gained the respect and admiration of many Thai people by inspiring them to be more conscious of their health. She has constantly highlighted the importance of healthy living and proper nutrition while enjoying an active lifestyle," said Mr Suphot Rittipichaiwat, General Manager, Herbalife Nutrition Thailand. "We are fortunate to have her as our Brand Ambassador as we believe she can bring a better understanding of health, nutrition and wellness to more people in the country."

Yossavadee Hassadeevichit said, "I would like to thank Herbalife Nutrition for giving me a platform to share my passion for sports and health. I am looking forward to many projects and activities this year that will engage people on their well-being. I am very proud to partner with Herbalife Nutrition as an advocate of good health."

For more information on Herbalife Nutrition in Thailand, please visit www.Herbalife.co.th our Facebook page or call 02-660-1600.

Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Related Topics